THE COMMON COLD HANDOUT the Common Cold, Also Called an Upper Respiratory Infection
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Factor That Should Raise Awareness in the Practice of Pediatric Medicine: West Nile Virus
Case Report / Olgu Sunumu DOI: 10.5578/ced.201813 • J Pediatr Inf 2018; 12(2): e70-e72 A Factor That Should Raise Awareness in the Practice of Pediatric Medicine: West Nile Virus Çocuk Hekimliği Pratiğinde Farkındalığın Artması Gereken Bir Etken; Batı Nil Virüsü Duygu Uç1, Tamer Çelik1, Derya Gönen1, Asena Sucu1, Can Celiloğlu1, Orkun Tolunay1, Ümit Çelik1 1 Clinics of Pediatrics, Adana City Training and Research Hospital, Adana, Turkey Abstract Özet West Nile virus is an RNA virus found in Flaviviridae family and its vector Batı Nil virüsü Flaviviridae ailesinde yer alan bir RNA virüsü olup, vektörü is of Culex-type mosquitoes and the population of these flies soar dra- Culex türü sivrisineklerdir. Culex türü sineklerin popülasyonu Ağustos matically in August. Most of the infected people who have mild viremia ayında pik yapmaktadır. Ilımlı viremiye sahip enfekte bireylerin çoğu experience this disease asymptomatically or encounter situations simi- hastalığı asemptomatik geçirmekte ya da diğer viral enfeksiyonlara ben- lar to other viral infections. Patients suffer from fatigue, fever, and head- zeyen tablolarla karşımıza gelmektedir. Hastalarda sıklıkla halsizlik, ateş, ache, pain in the eyes, myalgia, diarrhea, vomiting, arthralgia, rash and baş ağrısı, gözlerde ağrı, miyalji, ishal, kusma, artralji, döküntü ve lenfa- lymphadenopathy. Similar to many diseases transmitted through mos- denopati görülebilmektedir. Sivrisinekler aracılığı ile bulaşan birçok has- quitoes, the West Nile virus should also be considered as a problem of talık -
Information About Cough Medicine (DXM)
Myth: Abusing Over-The-Counter Drugs Are Safe Vancouver Island Information Teens may mistakenly believe that cough Youth & Family medicines sold in stores are less dangerous than about Cough street drugs. Even parents may underestimate Addiction Services the seriousness of DXM abuse and feel relief Medicine (DXM) that their children are "only abusing cough syrup, not illegal drugs." Although cough What is Dextromethorphan (DXM)? medicine is sold in stores and is a regulated product, the reality is that taking large quantities of DXM has the potential to be extremely Dextromethorphan (DXM) is a cough dangerous and even fatal. When taken in suppressant ingredient contained in over-the-counter medicines. combination with other medicines or illicit drugs DXM is found the risk increases significantly. in more than 100 over-the-counter If A Teen Is Using cough and cold medications in syrup, tablet, lozenge Sit down with the youth and openly voice your and capsule form. Taken in suspicions but avoid direct accusations. Do not suggested doses, DXM is have this conversation when the youth is under generally a safe and the influence of a substance. Stay calm and effective rational. cough medication. Seek medical attention immediately if the youth is unresponsive to your voice, vomiting, very Dextromethorphan is found in over-the-counter pale or has a bluish tinge to the skin. cough medicines, including Alka-Seltzer Plus Cold and Cough, Dimetapp DM, For More Information Sudafed cough medicine, Robitussin, Tylenol Cough and Cold medicine, Vicks 44 Cough To find out about services in your community, Relief medicine and many more. -
The Common Cold.Pdf
PATIENT TEACHING AID The Common Cold PERFORATION ALONG TEAR Everyone has experienced the misery of the common Rhinovirus Infection cold. A cold causes familiar symptoms such as a runny nose, sore throat, congestion, postnasal drip, and cough. For most sufferers, these symptoms are annoying, but not serious. Cold symptoms gradually improve and disappear over 7 to 10 days without complications. Colds are viral infections, so treatment with an antibiotic is not helpful. The best treatment for a cold is rest, fluids, and nonprescription medicines to help relieve symptoms. Although there is no vaccine to prevent colds, the spread of cold viruses can be slowed by frequent hand washing and avoiding close contact with those suffering from a cold. ILLUSTRATION: KRISTEN WIENANDT MARZEJON 2016 MARZEJON WIENANDT KRISTEN ILLUSTRATION: Copyright Jobson Medical Information LLC, 2016 continued MEDICAL PATIENT TEACHING AID Antibiotics Should Not Be Used to Treat a Cold Colds are caused by a variety of viruses, most commonly rhinoviruses. These viruses are highly contagious, and they are spread through the air or when someone is in contact with an infected person or contaminated object. There is no good evidence that exposure to cold or being overheated © Jobson Medical Information LLC, 2016 LLC, Information Medical Jobson © increases the risk of contracting a cold. Although most Wash your hands thoroughly and frequently colds occur in the winter months, some viruses that cause to prevent the spread of cold viruses. colds are more common in the fall or spring. Infants and young children are more prone to colds, as are people with weakened immunity. -
Traveler's Diarrhea
THE PRE-TRAVEL CONSULTATION Dr. Becky Reece, MD Lead physician at Lifespan Center of Excellence for Tick-borne Diseases Newport Hospital May 6, 2017 Some Slides from Dr. Kojic, Director of The Miriam Hospital Travel clinic Overview Epidemiology General recommendations The traveller Diseases Diarrhea Vector and animal bite prevention Immunizations Other travel related recommendations Travelers’ Health Risks Of 100,000 travelers to a developing country for 1 month: 50,000 will develop some health problem 8,000 will see a physician 5,000 will be confined to bed 1,100 will be incapacitated in their work 300 will be admitted to hospital 50 will be air evacuated 1 will die Among more than 42,000 ill returned travelers seen between 2007 and 2011 in the GeoSentinel surveillance network, the most common syndromic diagnoses were: gastrointestinal (34%) febrile illnesses (23%) dermatologic illnesses (19%) Asia (32%) and sub-Saharan Africa (25%) were the most common regions where illnesses were acquired. Approximately 40 percent of ill travelers reported pretravel medical visits. Travelers visiting friends and relatives in their country of origin had a disproportionately high burden of serious febrile illness and very low rate of advice prior to travel. Steffen R et al. J Infect Dis 1987. 156:84-91 GeoSentinel Surveillance of Illness in Returned Travelers, 2007–2011Leder K, Torresi J, Libman MD, et al Ann Intern Med. 2013;6(158):456. Causes of death Cardiovascular deaths 49% Cardiovascular Injuries, accidents 22% Medical Injury top on list Egypt, Kenya, Homicide/Suicide India Infectious Disease Other Medical illnesses 13.7% Infectious causes 1% Other Hargarten S et al, Ann Emerg Med, 1991. -
Influenza Planning Guide for Alberta's Vulnerable Populations And
Pandemic (H1N1) 2009 10.29.2009 Influenza Planning Guide For Alberta’s Vulnerable Populations and Shelter Serving Agencies Pandemic Influenza Guide for Vulnerable Populations Page 1 Issued by: Pandemic Influenza Planning Liaison Committee - Vulnerable Populations Version 7, Approved by: Alberta Health Services Emergency Coordination Centre October 28, 2009 Table of Contents Introduction: Purpose of This Guide............................................................................................1 Responsibilities of Shelter Serving Agencies .............................................................................2 Pandemic Influenza Information ...................................................................................................2 What is influenza? ........................................................................................................................2 How is influenza spread? .............................................................................................................2 When is a person with influenza infectious? ................................................................................3 How long does influenza remain on surfaces? ............................................................................3 How can we distinguish influenza from the common cold? .........................................................3 How to deal with Influenza ...........................................................................................................4 Prevention, Control and -
Common Human Coronaviruses
Common Human Coronaviruses Common human coronaviruses, including types 229E, NL63, OC43, and HKU1, usually cause mild to moderate upper-respiratory tract illnesses, like the common cold. Most people get infected with one or more of these viruses at some point in their lives. This information applies to common human coronaviruses and should not be confused with Coronavirus Disease-2019 (formerly referred to as 2019 Novel Coronavirus). Symptoms of common human coronaviruses Treatment for common human coronaviruses • runny nose • sore throat There is no vaccine to protect you against human • headache • fever coronaviruses and there are no specific treatments for illnesses caused by human coronaviruses. Most people with • cough • general feeling of being unwell common human coronavirus illness will recover on their Human coronaviruses can sometimes cause lower- own. However, to relieve your symptoms you can: respiratory tract illnesses, such as pneumonia or bronchitis. • take pain and fever medications (Caution: do not give This is more common in people with cardiopulmonary aspirin to children) disease, people with weakened immune systems, infants, and older adults. • use a room humidifier or take a hot shower to help ease a sore throat and cough Transmission of common human coronaviruses • drink plenty of liquids Common human coronaviruses usually spread from an • stay home and rest infected person to others through If you are concerned about your symptoms, contact your • the air by coughing and sneezing healthcare provider. • close personal contact, like touching or shaking hands Testing for common human coronaviruses • touching an object or surface with the virus on it, then touching your mouth, nose, or eyes before washing Sometimes, respiratory secretions are tested to figure out your hands which specific germ is causing your symptoms. -
Influenza (PDF)
INFLUENZA Outbreaks of influenza, or “flu”, typically occur every winter. Colds may occur at any time of year with seasonal peaks occurring in fall and spring. Influenza is a respiratory illness usually caused by infection with one of two influenza viruses – influenza A or influenza B. Outbreaks of influenza (flu) typically occur every winter. Influenza is characterized by an abrupt onset of fever, chills, headache, body aches, and lack of energy accompanied by respiratory symptoms, most frequently cough and sore throat. Most people are largely recovered in one week, although many feel fatigued for several weeks. Serious complications of flu, such as pneumonia, however, can occur, especially if the body’s defenses are weakened by age or disease. Influenza is spread by inhaling the influenza virus which is usually carried on tiny, invisible water droplets in the air generated by coughs and sneezes. Hand-to-hand contact as well as contact with infected secretions on a hard surface may also cause transmission of the virus. Each year influenza viruses change and new vaccines are made to combat the particular strains that are expected to cause illness that year. The flu vaccine may reduce the chance of getting the flu by 60-80%, and lessen the severity of illness in the person who does get the flu. According to the Centers for Disease Control (CDC), everyone 6 months or order should get a yearly flu vaccine. The following people are at high risk for complications of flu and are especially urged to get vaccinated: Individuals with chronic heart or lung problems that have required regular medical follow-up or hospitalization during the last year. -
Aids for Management of Common Headache Disorders in Primary Care
J Headache Pain (2007) 8:S1 DOI 10.1007/s10194-007-0366-y Lifting The Burden: The Global Campaign to Reduce the Burden of Headache Worldwide in collaboration with European Headache Federation Aids for management of common headache disorders in primary care This is a "Springer Open Choice" article. Unrestricted non-commercial use, distribution, and reproduction in any medium is permitted, provided the original author and source are credited. J Headache Pain (2007) 8:S2 PREFACE T.J. Steiner Aids for management of common headache P. Martelletti disorders in primary care T.J. Steiner Medical management of headache Whilst the focus of this publication Chairman: Global Campaign Committee disorders, for the vast majority of is Europe, these management aids Lifting The Burden people affected by them, can and have been developed to be useful should be carried out in primary cross-culturally and may suit a P. Martelletti care. It does not require specialist wider population. Editor-in-Chief Journal of Headache and Pain skills. Nonetheless, it is recognised The European principles of that non-specialists throughout management of common headache Europe may have received limited disorders in primary care are the training in the diagnosis and treat- essential core of these aids. These ment of headache. are set out in 12 sections, each one This special supplement of Journal more-or-less stand-alone. They are of Headache and Pain is the out- supplemented in Appendices 1 and put of a collaboration between the 2 by a measure of headache burden European Headache Federation (the HALT index), intended for (EHF) and Lifting The Burden: the pre-treatment assessment of illness Global Campaign to Reduce the severity, an outcome measure (the Burden of Headache Worldwide, a HART index), which is a guide to programme for the benefit of peo- follow-up and need for treatment- ple with headache conducted under review, and a series of patient the auspices of the World Health information leaflets developed to Organization. -
BUFFERIN Light Search
Read this sheet in full before using, and keep for later reference. Find more product info online Search BUFFERIN Light Light formula designed to be easy on the body* <Pain reliever/fever reducer> BUFFERIN Light Designated Class 2 OTC drugs Some BUFFERIN brand products contain different active ingredients. The pain relieving/fever reducing ingredient in this product is acetylsalicylic acid. When consulting a doctor, dentist, pharmacist or registered seller about this product, specify that the product you are asking about contains acetylsalicylic acid. BUFFERIN Light Formula Mild effectiveness* Contains no drowsiness-inducing ingredients Easy on the stomach Caffeine-free * The BUFFERIN Light formula contains a lower dose of analgesic ingredients than BUFFERIN A and contains ingredients that help protect the stomach Warnings Do not (Failure to comply with these instructions increases the likelihood of current symptoms worsening, side effects occurring, and other potentially serious risks) 1. Do not use this product if you (1) Have ever had an allergic reaction to this product or any of its ingredients (2) Have ever had an asthma attack after using this product, any other pain reliever/fever reducer, or a cold medicine (3) Are under 15 years old (4) Are pregnant and expecting to give birth within 12 weeks 2. Do not take any of the following pharmaceuticals while using this product Other pain relievers/fever reducers, cold medicines, sedatives 3. Do not consume alcohol before or after taking this product 4. Do not use this product continuously for extended periods Seek advice 1. Ask a doctor, dentist, pharmacist or registered seller before use if you are (1) Currently receiving treatment from a doctor or dentist (2) Pregnant or suspect you may be pregnant (3) Breast-feeding (4) Elderly 1 (5) Have ever shown allergic symptoms when taking a drug or medicine (6) Have been diagnosed with any of the following conditions: Heart disease; kidney disease; liver disease; stomach or duodenal ulcer 2. -
Drug Alliance Information Alert Stackers, DMX: Coricidin & Robitussin Abuse and Ephedrine
Drug Alliance Information Alert Stackers, DMX: Coricidin & Robitussin Abuse and Ephedrine • STACKERS are legal; over the counter dietary supplements used to assist in weight loss and muscle enhancement. These supplements can be extremely dangerous to your teenager's health . They are available at local drug and vitamin stores and gas stations. Ephedrine, the main ingredient, is a natural herb and therefore not currently regulated by the FDA. The FDA is now considering regulation, as a result of many young, health -conscious people suffering from strokes, heart conditions, and other serious illnesses related to stacker use. It has also been linked to anxiety, sleeplessness, migraines, high blood pressure, and seizures and in some instances ephedra has been link ed with death. • DMX: CORICIDIN & ROBITUSSIN ABUSE - Teens are abusing over - the -counter cold pills to get high The latest craze among teens is using over -the -counter cold medicines and cough syrup in excessive doses as recreational drugs b+ deliberately ing esting large amounts of Coricidin HBP -Cough & Cold Pills or Robitussin b+ as many as 15 tablets at once. The ingredient is DXM or dextromethorphan: a legal cough medicine ingredient which is uncontrolled by the government and is available in over 125 diffe rent products. These medicines can be purchased off the drugstore or supermarket counter. When used correctly, DXM suppresses coughs safely, but in large amounts it produces a chemical imbalance in the brain that allows the kids to get high. The DEA says abusers report an LSD -like high: a heightened sense of perceptual awareness, altered time perception and visual hallucinations. -
Important Pharmacy Information There Is No Copay When Your Primary Care Provider (PCP) Or Unitedhealthcare Community Plan Specialist Writes You a Covered Prescription
Important Pharmacy Information There is no copay when your Primary Care Provider (PCP) or UnitedHealthcare Community Plan Specialist writes you a covered prescription. But you can get many over-the-counter (OTC) medicines free when you have a prescription. You can get the medications listed on the following pages when they are medically necessary and you get a written prescription from your UnitedHealthcare Community Plan doctor and take it to a UnitedHealthcare Community Plan pharmacy. To get your medicine: • Take your prescription to a UnitedHealthcare Community Plan pharmacy. To find a pharmacy, call 1-800-903-5253 or go to UHCCommunityPlan.com. • For your safety, we urge you to select a single pharmacy from which to get your drugs. • Get to know the pharmacist and build a relationship. If the UnitedHealthcare Community Plan pharmacy says they cannot fill your covered prescription or you have to pay more than your copay: Do not leave the pharmacy. Do not pay for it yourself. Ask the pharmacy why they cannot fill your prescription. Response Your Solution Not Covered • Ask them to call OptumRx right away to find out which medicine is covered. • Ask them to call your doctor to see if you can get the covered medicine instead. Prior • Ask them to call your doctor for a prior authorization. Authorization • You can call your doctor and ask that a prior authorization be sent to: Needed UnitedHealthcare Pharmacy Prior Notification Service Fax 1-866-940-7328 Phone 1-800-310-6826 Refill Too Soon • Ask what day it can be filled. • Pick your prescription up the day it can be filled. -
National Guidelines for Clinical Management of Chikungunya 2016
CONTENTS Chapter Name of the Chapter Page No. 1 INTRODUCTION 1 2 Chikungunya: Status & disease burden 2-4 2.1 Transmission & trends 2 2.2 Global situation 2 2.3 Chikungunya in India (Past & present) 2-4 3 Laboratory diagnosis of Chikungunya f ever 5-7 3.1 Types of Laboratory tests available and specimens required: 5-6 3.2 Interpretation of results: 6 3.3 NVBDCP Laboratory Network: 6-7 3.4 Laboratory confirmation in case of Chikungunya outbreak 7 4 Case definition and differential diagnos is 8-9 4.1 Case definition 8 4.2 Differential diagnosis 8-9 5 Clinical manifestation of Chikungunya 10-16 5.1 Incubation period 10 5.2 Clinical Features: 10 5.3 Clinical Classification of severity of Chikungunya: 11 5.4 High Risk group: 11-12 5.5 Fever 12 5.6 Arthralgia 12 5.7 Back ache 12 5.8 Headache 13 5.9 Rash: 13 5.10 Stomatitis and oral ulcers : 13 5.11 Hyperpigmentation 13 5.12 Exfoliative dermatitis 13 5.13 Retrobulbar pain 13 5.14 Neurological manifestations 13 5.15 Occular manifestations 13 5.16 Chikungunya in Children 13-14 5.17 Impact of Chikungunya in Pregnancy & Neonates 14 5.17 Chikungunya in Elderly 14 5.18 Chikungunya Co infection with Dengue 14-15 5.19 Sequelae: 15 5.20 Mortality 15 5.21 Pathogenesis 16 6 Cl inical management of Chikungunya cases 17-20 6.1 Guiding principles of clinical management 17-18 6.2 Hospital based 18-19 6.3 Guiding principles for managing chronic pain 19 6.4 Summary 19-20 7 Public Health Measures 21-22 7.1 Minimizing transmissio n of infection: Annexure 1 Virus Genotype of Chikungunya virus 23-24 Vector Transmission Cycle References and Further study 25-26 Draft Chapter 1 INTRODUCTION Chikungunya fever is a viral disease transmitted to humans by the bite of infected Aedes aegypti mosquitoes.